Related Experiment Video
Updated: Jul 9, 2025
Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
Published on: April 13, 2015
Deciphering tumor-infiltrating dendritic cells in the single-cell era
Qingyu Huang1, Fuhao Wang1, Di Hao2
1Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, China.
Insights
Single-cell sequencing reveals diverse dendritic cell (DC) subtypes within tumors. Understanding these DC populations is key to developing new cancer immunotherapies and biomarkers.
Area of Science:
- Immunology
- Oncology
- Genomics
Background:
- Dendritic cells (DCs) are crucial for linking innate and adaptive immunity by processing tumor antigens and activating T cells.
- The tumor microenvironment (TME) contains diverse DC populations that influence anti-tumor responses.
- Single-cell sequencing has enabled high-resolution characterization of this DC heterogeneity.
Purpose of the Study:
- To review current knowledge on DC subtypes within the TME.
- To summarize findings from single-cell studies across various human tumors.
- To highlight the roles of distinct DC subsets in tumor immunity and their potential as biomarkers and therapeutic targets.
Main Methods:
- Comprehensive literature review of single-cell sequencing studies in human tumors.
- Focus on categorization, functions, and interactions of DC subsets.
- Analysis of DC roles in orchestrating tumor-related immune responses.
Main Results:
- Single-cell sequencing has uncovered significant heterogeneity within DC populations in the TME.
- Distinct DC subsets exhibit varied functional capabilities and interactions within the tumor milieu.
- These findings provide insights into the complex immune dynamics within tumors.
Conclusions:
- Understanding DC heterogeneity in the TME is vital for advancing cancer immunology.
- DC subtypes represent potential predictive biomarkers for immunotherapy response.
- Targeting specific DC populations may lead to more effective cancer immunotherapies.
Abstract:
Dendritic cells (DCs) serve as a pivotal link connecting innate and adaptive immunity by processing tumor-derived antigens and activating T cells. The advent of single-cell sequencing has revolutionized the categorization of DCs, enabling a high-resolution characterization of the previously unrecognized diversity of DC populations infiltrating the intricate tumor microenvironment (TME). The application of single-cell sequencing technologies has effectively elucidated the heterogeneity of DCs present in the tumor milieu, yielding invaluable insights into their subpopulation structures and functional diversity. This review provides a comprehensive summary of the current state of knowledge regarding DC subtypes in the TME, drawing from single-cell studies conducted across various human tumors. We focused on the categorization, functions, and interactions of distinct DC subsets, emphasizing their crucial roles in orchestrating tumor-related immune responses. Additionally, we delve into the potential implications of these findings for the identification of predictive biomarkers and therapeutic targets. Enhanced insight into the intricate interplay between DCs and the TME promises to advance our comprehension of tumor immunity and, in turn, pave the way for the development of more efficacious cancer immunotherapies.
More Related Videos
08:32Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
Published on: June 7, 2018
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021